Earnings results for Agenus (NASDAQ:AGEN)
Agenus Inc. is expected* to report earnings on 10/29/2020 before market open. The report will be for the fiscal Quarter ending Sep 2020. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.26. The reported EPS for the same quarter last year was $-0.33.
Agenus last issued its quarterly earnings results on August 6th, 2020. The biotechnology company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.01. The business earned $26.95 million during the quarter, compared to analyst estimates of $9.33 million. Agenus has generated ($0.80) earnings per share over the last year. Agenus has confirmed that its next quarterly earnings report will be published on Thursday, October 29th, 2020.
Analyst Opinion on Agenus (NASDAQ:AGEN)
3 Wall Street analysts have issued ratings and price targets for Agenus in the last 12 months. Their average twelve-month price target is $7.00, predicting that the stock has a possible upside of 89.70%. The high price target for AGEN is $8.00 and the low price target for AGEN is $6.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Agenus has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $7.00, Agenus has a forecasted upside of 89.7% from its current price of $3.69. Agenus has only been the subject of 2 research reports in the past 90 days.
Dividend Strength: Agenus (NASDAQ:AGEN)
Agenus does not currently pay a dividend. Agenus does not have a long track record of dividend growth.
Insiders buying/selling: Agenus (NASDAQ:AGEN)
In the past three months, Agenus insiders have not sold or bought any company stock. Only 4.70% of the stock of Agenus is held by insiders. 49.07% of the stock of Agenus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of Agenus (NASDAQ:AGEN
Earnings for Agenus are expected to decrease in the coming year, from ($1.02) to ($1.07) per share. The P/E ratio of Agenus is -3.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Agenus is -3.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
More latest stories: here